Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer
Open Access
- 25 September 2021
- journal article
- research article
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2021, 1-12
- https://doi.org/10.1155/2021/9715154
Abstract
Ginsenoside Rh2 (Rh2) is one of the pharmacologically active components of ginseng with an antitumor effect. However, its effect on non-small-cell lung cancer (NSCLC), especially on aerobic glycolysis, which plays a crucial role in the proliferation and progression of tumor cells, has not been characterized. Here, we demonstrated that Rh2 inhibited the proliferation and metastasis of NSCLC cells by promoting apoptosis and suppressing epithelial-mesenchymal transition, respectively. Notably, Rh2 exerted a glycolysis inhibition effect through regulating GLUT1, PKM2, and LDHA, which are key enzymes of the glycolysis process. Furthermore, the metabolic shift function of Rh2 was dependent on the STAT3/c-Myc axis in NSCLC. This novel regulatory role of Rh2 provides a new perspective for NSCLC treatment and highlights the potentiality of Rh2 to be used as a tumor energy blocker. The combination of Rh2 with an STAT3 or c-Myc inhibitor revealed a promising therapeutic approach for patients with NSCLC.Funding Information
- Administration of Traditional Chinese Medicine of Jilin Province (2021095, 82103343, 2018J021, 202002063JC)
This publication has 32 references indexed in Scilit:
- The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanismHuman Cell, 2018
- Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cellsMolecular Medicine Reports, 2018
- Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cellsBiomedicine & Pharmacotherapy, 2017
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- The in Vitro Structure-Related Anti-Cancer Activity of Ginsenosides and Their DerivativesMolecules, 2011
- Dysregulated pH: a perfect storm for cancer progressionNature Reviews Cancer, 2011
- [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].2011
- Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cellsFitoterapia, 2010
- 20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicityBioorganic & Medicinal Chemistry Letters, 2009
- Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cellsCancer Chemotherapy and Pharmacology, 2005